Drug Shortage Report for BRINEURA
| Report ID | 222042 |
| Drug Identification Number | 02484013 |
| Brand name | BRINEURA |
| Common or Proper name | CERLIPONASE ALFA INJECTION |
| Company Name | BIOMARIN INTERNATIONAL LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | CERLIPONASE ALFA |
| Strength(s) | 150MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRACEREBROVENTRICULAR INTRACEREBROVENTRICULAR |
| Packaging size | Each pack contains two vials, each containing 150 mg/5 ml cerliponase alfa, and one vial 5 ml of flushing solution |
| ATC code | A16AB |
| ATC description | |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2024-08-05 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2024-03-13 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | SHANBALLY RINGASKIDDY, CORK IRELAND P43R298 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2024-03-13 | French | Compare |
| v3 | 2024-03-13 | English | Compare |
| v2 | 2024-03-13 | French | Compare |
| v1 | 2024-03-13 | English | Compare |
Showing 1 to 4 of 4